Literature DB >> 12894081

Fatal interstitial pulmonary fibrosis in anti-Jo-1-negative amyopathic dermatomyositis.

Whitney A High1, Jack B Cohen, Bettina A Murphy, Melissa I Costner.   

Abstract

Amyopathic dermatomyositis (DM) describes a subpopulation with the cutaneous eruption of DM, but without muscle involvement. Interstitial pulmonary fibrosis is a recognized complication of DM, often correlated with antisynthetase enzymes, such as anti-Jo-1. We describe a case of fatal IPF in a patient with anti-Jo-1 antibody-negative amyopathic DM.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12894081     DOI： 10.1067/s0190-9622(03)01482-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  3 in total

1.  Amyopathic dermatomyositis complicated by pneumomediastinum.

Authors:  Randy Tang; Christian R Millett; Justin J Green
Journal:  J Clin Aesthet Dermatol       Date:  2013-03

2.  Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?

Authors:  Satoshi Ikeda; Machiko Arita; Mitsunori Morita; Satoshi Ikeo; Akihiro Ito; Fumiaki Tokioka; Maki Noyama; Kenta Misaki; Kenji Notohara; Tadashi Ishida
Journal:  BMC Pulm Med       Date:  2015-12-09       Impact factor: 3.317

3.  Impact of adding tacrolimus to initial treatment of interstitial pneumonitis in polymyositis/dermatomyositis: a single-arm clinical trial.

Authors:  Kazuki Takada; Yoshinori Katada; Satoshi Ito; Taichi Hayashi; Jun Kishi; Kenji Itoh; Hiroyuki Yamashita; Michito Hirakata; Kimito Kawahata; Atsushi Kawakami; Norihiko Watanabe; Tatsuya Atsumi; Yoshinari Takasaki; Nobuyuki Miyasaka
Journal:  Rheumatology (Oxford)       Date:  2020-05-01       Impact factor: 7.580
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.